Viatrinil 1mg/ml Solution For Injection, 5 Ampoules (Granisetron)
Viatrinil is indicated in adults for the prevention and treatment of:
- acute nausea and vomiting associated with chemotherapy and radiotherapy.
- post-operative nausea and vomiting.
Viatrinil is indicated for the prevention of delayed nausea and vomiting associated with chemotherapy and radiotherapy.
Viatrinil is indicated in children aged 2 years and above for the prevention and treatment of acute nausea and vomiting associated with chemotherapy.
Share Now
Additional Information
| Name | Viatrinil 1mg/ml solution for injection |
| Description | Granisetron is a potent anti-emetic and highly selective antagonist of 5-hydroxytryptamine (5- HT3 ) receptors. Radioligand binding studies have demonstrated that granisetron has negligible affinity for other receptor types including 5-HT and dopamine D2 binding sites. |
| Active Ingredient | Granisetron hydrochloride |
| Indication | Viatrinil is indicated in adults for the prevention and treatment of – acute nausea and vomiting associated with chemotherapy and radiotherapy. – post-operative nausea and vomiting. Viatrinil is indicated for the prevention of delayed nausea and vomiting associated with chemotherapy and radiotherapy. Viatrinil is indicated in children aged 2 years and above for the prevention and treatment of acute nausea and vomiting associated with chemotherapy. |
| Strengths | 1mg/ml solution for injection/infusion |
| Regulatory Status | Registered |
| Business Partner | VIANEX S.A |
| Origin | Athens-Greece |
Related Products
Disclaimer
Pharma Solution is the marketing agent and Distributor for the listed products for the Gulf and MENA region. The products are either registered and approved by the respective local health authority or contracted by the MAH to supply to the end users on a named patient basis. Some products such as Orphan drugs, rare diseases medicines are imported based on special import permits and as per need of the Hospitals in compliance with full documentation.
